Replication organelles of hepatitis C virus and SARS-CoV-2: Surprising similarities and avenues for broad-spectrum antivirals

被引:0
|
作者
Roingeard, Philippe [1 ,2 ,3 ,4 ]
机构
[1] Univ Tours, Inserm, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
[2] Univ Tours, Plateforme IBiSA Microscopie Elect, 10 Blvd Tonnelle, F-37032 Tours, France
[3] CHU Tours, 10 Blvd Tonnelle, F-37032 Tours, France
[4] Inserm, Fac Med Tours, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
来源
关键词
COVID-19; Severe acute respiratory syndrome; Hepatitis C; RNA virus infections; Virus replication; Antiviral agents; CORONAVIRUS REPLICATION; ENDOPLASMIC-RETICULUM; PROTEINS; RNA;
D O I
10.1016/j.banm.2023.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Positive single -strand RNA (+RNA) viruses can remodel host cell membranes to induce replication organelles isolating the replication of their genome from cellular innate immunity mechanisms. Some of these viruses, including the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), induce double-membrane vesicles (DMV) to behave as replication organelles. As for the hepatitis C virus (HCV), pores crossing both membranes of SARS-CoV-2-induced DMV have been identified. These pores likely allow the supply of metabolites essential for viral replication within the DMV, and allow the export of the newly synthesized viral RNA to form the genome of the neo-synthesized virions. However, it remains unknown whether DMV with open pores can coexist with fully sealed DMV allowing the storage of large amounts of viral RNA, as seen for the HCV model. Interestingly, recent studies have revealed many similarities in the mechanisms of DMV biogenesis between these two phylogenetically distant viruses. Understanding the mechanisms of DMV formation and function will be essential for the development of new broad-spectrum antiviral approaches, able to inhibit DMV-inducing viruses from different families. (c) 2023 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 50 条
  • [31] Reply to the spectrum of SARS-CoV-2 associated polyradiculitis is broad
    Wang, Y.
    Wang, Y.
    Li, X.
    Wang, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (11) : 836 - 837
  • [32] Inhaled Dry Powder Formulation of Tamibarotene, a Broad-Spectrum Antiviral against Respiratory Viruses Including SARS-CoV-2 and Influenza Virus
    Liao, Qiuying
    Yuan, Shuofeng
    Cao, Jianli
    Tang, Kaiming
    Qiu, Yingshan
    Seow, Han Cong
    Man, Rico Chi-Hang
    Shao, Zitong
    Huang, Yaoqiang
    Liang, Ronghui
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    Lam, Jenny Ka-Wing
    ADVANCED THERAPEUTICS, 2021, 4 (07)
  • [33] Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants
    Bi, Wenwen
    Chen, Guilin
    Dang, Bobo
    JOURNAL OF VIROLOGY, 2022, 96 (13)
  • [34] System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2
    Vicenti, Ilaria
    Martina, Maria Grazia
    Boccuto, Adele
    De Angelis, Marta
    Giavarini, Giorgia
    Dragoni, Filippo
    Marchi, Serena
    Trombetta, Claudia Maria
    Crespan, Emmanuele
    Maga, Giovanni
    Eydoux, Cecilia
    Decroly, Etienne
    Montomoli, Emanuele
    Nencioni, Lucia
    Zazzi, Maurizio
    Radi, Marco
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [35] Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
    Chi, Xiangyang
    Xia, Lingyun
    Zhang, Guanying
    Chi, Ximin
    Huang, Bangdong
    Zhang, Yuanyuan
    Chen, Zhengshan
    Han, Jin
    Wu, Liushu
    Li, Zeya
    Sun, Hancong
    Huang, Ping
    Yu, Changming
    Chen, Wei
    Zhou, Qiang
    CELL DISCOVERY, 2023, 9 (01)
  • [36] Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug
    Wang, Yu-Chuan
    Yang, Wen-Hao
    Yang, Chia-Shin
    Hou, Mei-Hui
    Tsai, Chia-Ling
    Chou, Yi-Zhen
    Hung, Mien-Chie
    Chen, Yeh
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (08): : 2535 - +
  • [37] A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains
    Yao, Hebang
    Wang, Hongyang
    Zhang, Zhaoyong
    Lu, Yuchi
    Zhang, Zhiying
    Zhang, Yu
    Xiong, Xinyi
    Wang, Yanqun
    Wang, Zhizhi
    Yang, Haitao
    Zhao, Jincun
    Xu, Wenqing
    MEDCOMM, 2023, 4 (06):
  • [38] Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
    Subhadra, Bobban
    Agrawal, Ragini
    Pal, Virender Kumar
    Chenine, Agnes-Laurence
    Mattathil, Jeffy George
    Singh, Amit
    VIRUSES-BASEL, 2023, 15 (06):
  • [39] Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2
    Dai, Wenhao
    Jochmans, Dirk
    Xie, Hang
    Yang, Hang
    Li, Jian
    Su, Haixia
    Chang, Di
    Wang, Jiang
    Peng, Jingjing
    Zhu, Lili
    Nian, Yong
    Hilgenfeld, Rolf
    Jiang, Hualiang
    Chen, Kaixian
    Zhang, Leike
    Xu, Yechun
    Neyts, Johan
    Liu, Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2794 - 2808
  • [40] Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
    Xiangyang Chi
    Lingyun Xia
    Guanying Zhang
    Ximin Chi
    Bangdong Huang
    Yuanyuan Zhang
    Zhengshan Chen
    Jin Han
    Liushu Wu
    Zeya Li
    Hancong Sun
    Ping Huang
    Changming Yu
    Wei Chen
    Qiang Zhou
    Cell Discovery, 9